1-3 of 3
Jacalyn Rosenblatt
Close
Sort by
Journal Articles

Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma

Clinical Trials & Observations
Matthew J. Frigault, Michael R. Bishop, Jacalyn Rosenblatt, Elizabeth K. O’Donnell, Noopur Raje, Daniella Cook, Andrew J. Yee, Emma Logan, David E. Avigan, Andrzej Jakubowiak, Kit Shaw, Heather Daley, Sarah Nikiforow, Faith Griffin, Christine Cornwell, Angela Shen, Christopher Heery, Marcela V. Maus
Journal: Blood Advances
Blood Adv (2023) 7 (5): 768–777.
https://doi.org/10.1182/bloodadvances.2022007210
Published: 2023
Includes: Supplemental data
Journal Articles

GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial

Clinical Trials & Observations
Vincent T. Ho, Haesook T. Kim, Jennifer Brock, Ilene Galinsky, Heather Daley, Carol Reynolds, Augustine Weber, Olga Pozdnyakova, Mariano Severgnini, Sarah Nikiforow, Corey Cutler, John Koreth, Edwin P. Alyea, III, Joseph H. Antin, Mahasweta Gooptu, Rizwan Romee, Roman Shapiro, Yi-Bin Chen, Jacalyn Rosenblatt, David Avigan, F. Stephen Hodi, Glenn Dranoff, Catherine J. Wu, Jerome Ritz, Robert J. Soiffer
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2183–2194.
https://doi.org/10.1182/bloodadvances.2021006255
Published: 2022
Includes: Supplemental data
Journal Articles

Phase 1 study of the Hedgehog pathway inhibitor sonidegib for steroid-refractory chronic graft-versus-host disease

Clinical Trials & Observations
Zachariah DeFilipp, Rosalynn M. Nazarian, Areej El-Jawahri, Shuli Li, Jami Brown, Candice Del Rio, Melissa Smith, Betsy Valles, Karen K. Ballen, Steven L. McAfee, Jacalyn Rosenblatt, Joseph H. Antin, Corey S. Cutler, Yi-Bin Chen
Journal: Blood Advances
Blood Adv (2017) 1 (22): 1919–1922.
https://doi.org/10.1182/bloodadvances.2017011239
Published: 2017